Long-term #PFA data matters. FARAPULSE™ PFA delivered.
ADVENT LTO was the first clinical study to report outcomes out to 4 years from a randomized cohort of patients comparing PFA vs. thermal ablation, showing FARAPULSE™ PFA outperformed thermal. See the full study: qrco.de/bgbmX9
ADVENT LTO was the first clinical study to report outcomes out to 4 years from a randomized cohort of patients comparing PFA vs. thermal ablation, showing FARAPULSE™ PFA outperformed thermal. See the full study: qrco.de/bgbmX9
February 7, 2026 at 2:28 PM
Long-term #PFA data matters. FARAPULSE™ PFA delivered.
ADVENT LTO was the first clinical study to report outcomes out to 4 years from a randomized cohort of patients comparing PFA vs. thermal ablation, showing FARAPULSE™ PFA outperformed thermal. See the full study: qrco.de/bgbmX9
ADVENT LTO was the first clinical study to report outcomes out to 4 years from a randomized cohort of patients comparing PFA vs. thermal ablation, showing FARAPULSE™ PFA outperformed thermal. See the full study: qrco.de/bgbmX9
Day 2 of this excellent event #TransformAF opened by Dr. Frank Marchilinski covering the evolution of atrial fibrillation ablation, followed by the clinical science behind #PFA, real world experience with #Farapulse and our @BSCCardiology full catheter portfolio. #epeeps
December 7, 2024 at 1:39 PM
Day 2 of this excellent event #TransformAF opened by Dr. Frank Marchilinski covering the evolution of atrial fibrillation ablation, followed by the clinical science behind #PFA, real world experience with #Farapulse and our @BSCCardiology full catheter portfolio. #epeeps
After having some reaccurnaces of afib last fall i decided to go for a 2nd ablation yesterday. Had this new technology, it’s been available in Europe for years, been approved by the FDA two years ago I likely wouldn’t have needed a re-do. youtu.be/BjDfsH-kozo?...
FARAPULSE™ Pulsed Field Ablation System Animation
YouTube video by Boston Scientific Cardiology
youtu.be
February 4, 2025 at 1:59 PM
After having some reaccurnaces of afib last fall i decided to go for a 2nd ablation yesterday. Had this new technology, it’s been available in Europe for years, been approved by the FDA two years ago I likely wouldn’t have needed a re-do. youtu.be/BjDfsH-kozo?...
On my way to Western Atrial Fibrillation Symposium in Salt Lake City, Utah. One of the bigger EP meetings in the world, but for me a first time. Looking forward to learning more from presenters and live cases. See you at #WAFIB2025
#epeeps #farapulse #PFA #OPAL #FARAVIEW
#epeeps #farapulse #PFA #OPAL #FARAVIEW
February 27, 2025 at 4:32 PM
On my way to Western Atrial Fibrillation Symposium in Salt Lake City, Utah. One of the bigger EP meetings in the world, but for me a first time. Looking forward to learning more from presenters and live cases. See you at #WAFIB2025
#epeeps #farapulse #PFA #OPAL #FARAVIEW
#epeeps #farapulse #PFA #OPAL #FARAVIEW
📊Catch the latest FARAPULSE™ PFA Platform data at #HRS2026. Don’t miss AVANT GUARD primary outcomes, the ELEVATE-PF feasibility study, in-booth roundtables and more.
View the full program:
qrco.de/bgikIt
FARAPULSE™ Pulsed Field Ablation System Indications, Safety, and Warnings: qrco.de/bfsrJX
View the full program:
qrco.de/bgikIt
FARAPULSE™ Pulsed Field Ablation System Indications, Safety, and Warnings: qrco.de/bfsrJX
April 7, 2026 at 1:00 PM
📊Catch the latest FARAPULSE™ PFA Platform data at #HRS2026. Don’t miss AVANT GUARD primary outcomes, the ELEVATE-PF feasibility study, in-booth roundtables and more.
View the full program:
qrco.de/bgikIt
FARAPULSE™ Pulsed Field Ablation System Indications, Safety, and Warnings: qrco.de/bfsrJX
View the full program:
qrco.de/bgikIt
FARAPULSE™ Pulsed Field Ablation System Indications, Safety, and Warnings: qrco.de/bfsrJX
What a pleasure to be in Washington DC these days, to attend and participate in #TransformAF, a Boston Scientific program around our Farapulse PFA technology. Several live cases, an amazing faculty and EP’s from around the US. #epeeps #farapulse #atrialfibrillation
December 6, 2024 at 7:33 PM
What a pleasure to be in Washington DC these days, to attend and participate in #TransformAF, a Boston Scientific program around our Farapulse PFA technology. Several live cases, an amazing faculty and EP’s from around the US. #epeeps #farapulse #atrialfibrillation
We’ve reimagined what’s possible for #PFA — a fully integrated future that’s driving innovation and shaping what’s next. The FARAPULSE™ PFA Platform is a transformative leap forward. Built for the EP lab, it provides tools from transseptal access to ablation to real-time mapping.
November 26, 2025 at 2:30 PM
We’ve reimagined what’s possible for #PFA — a fully integrated future that’s driving innovation and shaping what’s next. The FARAPULSE™ PFA Platform is a transformative leap forward. Built for the EP lab, it provides tools from transseptal access to ablation to real-time mapping.
Boston Scientific Unveils Innovative Therapies at Heart Rhythm 2026 Conference#USA#Chicago#Boston_Scientific#FARAPULSE#WATCHMAN
Boston Scientific Unveils Innovative Therapies at Heart Rhythm 2026 Conference
Boston Scientific highlighted their latest therapies at Heart Rhythm 2026, showcasing the FARAPULSE PFA Platform and WATCHMAN LAAC technologies with promising clinical trial data.
third-news.com
April 26, 2026 at 5:07 PM
Boston Scientific Unveils Innovative Therapies at Heart Rhythm 2026 Conference#USA#Chicago#Boston_Scientific#FARAPULSE#WATCHMAN
FARAPULSE™システムが心房細動治療を革新。3Dマッピング機能追加で実現する手技の効率化#東京都#中野区#ボストン・サイエンティフィック#FARAPULSE#PFA治療
FARAPULSE™パルスフィールドアブレーションシステムに新たに3Dマッピング機能が追加され、治療の正確性と効率が向上します。医療現場への影響も期待されています。
FARAPULSE™パルスフィールドアブレーションシステムに新たに3Dマッピング機能が追加され、治療の正確性と効率が向上します。医療現場への影響も期待されています。
FARAPULSE™システムが心房細動治療を革新。3Dマッピング機能追加で実現する手技の効率化
FARAPULSE™パルスフィールドアブレーションシステムに新たに3Dマッピング機能が追加され、治療の正確性と効率が向上します。医療現場への影響も期待されています。
news.3rd-in.co.jp
April 30, 2025 at 6:47 AM
FARAPULSE™システムが心房細動治療を革新。3Dマッピング機能追加で実現する手技の効率化#東京都#中野区#ボストン・サイエンティフィック#FARAPULSE#PFA治療
FARAPULSE™パルスフィールドアブレーションシステムに新たに3Dマッピング機能が追加され、治療の正確性と効率が向上します。医療現場への影響も期待されています。
FARAPULSE™パルスフィールドアブレーションシステムに新たに3Dマッピング機能が追加され、治療の正確性と効率が向上します。医療現場への影響も期待されています。
Nice review of Farapulse PVI considerations
www.heartrhythmjournal.com/article/S154...
www.heartrhythmjournal.com/article/S154...
How to perform pulmonary vein isolation using a pentaspline pulsed field ablation system for treatment of atrial fibrillation
One of the most significant recent advances in developing new technologies for the
interventional treatment of atrial fibrillation (AF) has been the introduction of
pulsed field ablation (PFA).1 PFA d...
www.heartrhythmjournal.com
January 17, 2025 at 1:23 PM
Nice review of Farapulse PVI considerations
www.heartrhythmjournal.com/article/S154...
www.heartrhythmjournal.com/article/S154...
It's Day 2 at #TransformAF2025 and the energy is high! The EP community is coming together to advance care for more patients with FARAPULSE™ #PFA Platform and WATCHMAN FLX™ Pro #LAAC Device. #EPeeps
October 4, 2025 at 6:17 PM
It's Day 2 at #TransformAF2025 and the energy is high! The EP community is coming together to advance care for more patients with FARAPULSE™ #PFA Platform and WATCHMAN FLX™ Pro #LAAC Device. #EPeeps
The technology is intended to offer physicians an innovative imaging option for standalone WATCHMAN™ #LAAC Device procedures, FARAWATCH™ concomitant procedures utilizing the WATCHMAN LAAC Device and FARAPULSE™ PFA Platform, as well as other structural heart procedures. (2/2)
November 13, 2025 at 10:19 PM
The technology is intended to offer physicians an innovative imaging option for standalone WATCHMAN™ #LAAC Device procedures, FARAWATCH™ concomitant procedures utilizing the WATCHMAN LAAC Device and FARAPULSE™ PFA Platform, as well as other structural heart procedures. (2/2)
Field Medical has received FDA breakthrough designation for its FieldForce pulsed field ablation technology. It was also accepted the technology into the FDA's TAP program that facilitates rapid development and widespread access to medical devices. #medtech
🔗 www.massdevice.com/fda-grants-b...
🔗 www.massdevice.com/fda-grants-b...
FDA grants breakthrough nod to pulsed field ablation tech from Farapulse founder's Field Medical
Field Medical announced today that it received FDA breakthrough device designation for its FieldForce pulsed field ablation (PFA) system.
www.massdevice.com
December 6, 2024 at 12:50 PM
Field Medical has received FDA breakthrough designation for its FieldForce pulsed field ablation technology. It was also accepted the technology into the FDA's TAP program that facilitates rapid development and widespread access to medical devices. #medtech
🔗 www.massdevice.com/fda-grants-b...
🔗 www.massdevice.com/fda-grants-b...
FARAPULSE™ PFA platform enables a different approach to posterior wall ablation. The unique design of the FARAWAVE™ PFA Catheter enables uniform posterior wall substrate modification, unlike focal catheters that rely on posterior wall isolation.
Learn more: qrco.de/bgNqf1
#PFA #Epeeps
Learn more: qrco.de/bgNqf1
#PFA #Epeeps
October 16, 2025 at 1:17 PM
FARAPULSE™ PFA platform enables a different approach to posterior wall ablation. The unique design of the FARAWAVE™ PFA Catheter enables uniform posterior wall substrate modification, unlike focal catheters that rely on posterior wall isolation.
Learn more: qrco.de/bgNqf1
#PFA #Epeeps
Learn more: qrco.de/bgNqf1
#PFA #Epeeps
Address #Afib symptoms and reduce stroke risk in one concomitant streamlined case with the FARAPULSE™ PFA Platform and WATCHMAN FLX™ Pro LAAC Device, also known as FARAWATCH™. Learn more about the #FARAWATCH approach: qrco.de/bgX2uh
#LAAC #PulsedFieldAblation
#LAAC #PulsedFieldAblation
December 30, 2025 at 2:00 PM
Address #Afib symptoms and reduce stroke risk in one concomitant streamlined case with the FARAPULSE™ PFA Platform and WATCHMAN FLX™ Pro LAAC Device, also known as FARAWATCH™. Learn more about the #FARAWATCH approach: qrco.de/bgX2uh
#LAAC #PulsedFieldAblation
#LAAC #PulsedFieldAblation
LATE-BREAKING CLINICAL DATA: FARADISE real-world global registry highlights the safety and effectiveness of the FARAPULSE™ PFA system in over 1,100 patients.
🟣 1.5% primary adverse event rate
🟣 80.8% 12-month clinical effectiveness in paroxysmal AF
See the study: qrco.de/bgGsjd
#ESCCongress
🟣 1.5% primary adverse event rate
🟣 80.8% 12-month clinical effectiveness in paroxysmal AF
See the study: qrco.de/bgGsjd
#ESCCongress
September 3, 2025 at 1:10 PM
LATE-BREAKING CLINICAL DATA: FARADISE real-world global registry highlights the safety and effectiveness of the FARAPULSE™ PFA system in over 1,100 patients.
🟣 1.5% primary adverse event rate
🟣 80.8% 12-month clinical effectiveness in paroxysmal AF
See the study: qrco.de/bgGsjd
#ESCCongress
🟣 1.5% primary adverse event rate
🟣 80.8% 12-month clinical effectiveness in paroxysmal AF
See the study: qrco.de/bgGsjd
#ESCCongress
CAYMAN ISLANDS: Health City Performs Caribbean’s First FARAPULSE™ Procedure for Atrial Fibrillation
rcnworldwidemedia.blogspot.com/2026/07/caym...
rcnworldwidemedia.blogspot.com/2026/07/caym...
CAYMAN ISLANDS: Health City Performs Caribbean’s First FARAPULSE™ Procedure for Atrial Fibrillation
rcnworldwidemedia.blogspot.com
July 31, 2026 at 5:39 PM
CAYMAN ISLANDS: Health City Performs Caribbean’s First FARAPULSE™ Procedure for Atrial Fibrillation
rcnworldwidemedia.blogspot.com/2026/07/caym...
rcnworldwidemedia.blogspot.com/2026/07/caym...
The incidence of new-onset migraine was comparable between different systems; 1.69% (95% CI 1.10%-2.49%), 1.65% (95% CI 0.54%-3.82%), and 0.27% (95% CI 0.01%-1.50%) for Farapulse, Sphere 9, and Pulse Select, respectively. (🧵 7/9)
June 16, 2026 at 8:32 AM
The incidence of new-onset migraine was comparable between different systems; 1.69% (95% CI 1.10%-2.49%), 1.65% (95% CI 0.54%-3.82%), and 0.27% (95% CI 0.01%-1.50%) for Farapulse, Sphere 9, and Pulse Select, respectively. (🧵 7/9)
New-onset migraine was diagnosed in 31 (1.4%) post-PFA patients. Of these 31 patients, 25 (80.6%) underwent PFA using the Farapulse system, Sphere 9 in 5 (16.12%), and Pulse Select in 1 (3.22%) patient. (🧵 6/9)
June 16, 2026 at 8:32 AM
New-onset migraine was diagnosed in 31 (1.4%) post-PFA patients. Of these 31 patients, 25 (80.6%) underwent PFA using the Farapulse system, Sphere 9 in 5 (16.12%), and Pulse Select in 1 (3.22%) patient. (🧵 6/9)
October 20, 2025 at 10:04 PM
"Severance Hospital named global training hub for FARAPULSE PFA system"
#Health #Healthcare #ElderCare #MedSky
#Health #Healthcare #ElderCare #MedSky
Severance Hospital named global training hub for FARAPULSE PFA system
Severance Hospital will train physicians from around the world in the use of the FARAPULSE pulsed field ablation (PFA) system, the latest treatment for atrial fibrillation.The hospital said Friday it has been designated an International Training Center for the FARAPULSE PFA System -- the first such
www.koreabiomed.com
June 20, 2025 at 7:02 AM
"Severance Hospital named global training hub for FARAPULSE PFA system"
#Health #Healthcare #ElderCare #MedSky
#Health #Healthcare #ElderCare #MedSky
So far so good. Any luck with flouroless farapulse? I think we’ll start with varipulse.
November 23, 2024 at 1:40 PM
So far so good. Any luck with flouroless farapulse? I think we’ll start with varipulse.
$BSX +3.7% [Boston Scientific raised its 2025 profit forecast due to strong demand for heart devices like Farapulse & Watchman, which drove Q2 sales up 23% and net income to more than double.] news.bostonscientific.com/2025-07-23-B...
Boston Scientific announces results for second quarter 2025
Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.061 billion during the second quarter of 2025, growing 22.8 percent on a reported basis, 21.6 percent on an operational1 basis...
news.bostonscientific.com
July 23, 2025 at 2:14 PM
$BSX +3.7% [Boston Scientific raised its 2025 profit forecast due to strong demand for heart devices like Farapulse & Watchman, which drove Q2 sales up 23% and net income to more than double.] news.bostonscientific.com/2025-07-23-B...